HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies

BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Oncol
Egile Nagusiak: Satala, Catalin Bogdan, Jung, Ioan, Stefan-van Staden, Raluca Ioana, Kovacs, Zsolt, Molnar, Calin, Bara, Tivadar, Fulop, Zsolt Zoltan, Gurzu, Simona
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596543/
https://ncbi.nlm.nih.gov/pubmed/33144857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8860174
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak